Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study
Titel:
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study
Auteur:
Lassalle, A. Thomaré, P. Fronteau, C. Mahé, B. Jubé, C. Blin, N. Voldoire, M. Dubruille, V. Tessoulin, B. Touzeau, C. Chauvin, C. Loirat, M. Lok, A. Bourcier, J. Lestang, E. Mocquet, R. Barbarot, V. Moreau, P.